Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 87: 1035-1037, 1999;
8750-7587/99 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, R. R.
Right arrow Articles by van Bockxmeer, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, R. R.
Right arrow Articles by van Bockxmeer, F. M.
Vol. 87, Issue 3, 1035-1037, September 1999

Elite athletes and the gene for angiotensin-converting enzyme

Roger R. Taylor1, Cyril D. S. Mamotte2, Kieran Fallon3, and Frank M. van Bockxmeer2,4

1 Departments of Cardiology and Medicine, Royal Perth Hospital and The University of Western Australia, Perth, Western Australia 6001; 2 Department of Biochemistry, Royal Perth Hospital, Perth, Western Australia 6001; 3 Australian Institute of Sport, Belconnen, Australian Capital Territory 2616; and 4 Department of Pathology, The University of Western Australia, Nedlands, Western Australia 6009, Australia


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The deletion (D) allele of the gene for angiotensin-converting enzyme (ACE) is associated with higher plasma and tissue levels of the enzyme and has also been related to a variety of cardiovascular complications, particularly myocardial infarction. On the basis of indirect evidence, we hypothesized that inheritance of the D allele would contribute to elite athletic ability. Over a period of 4 yr, 120 Caucasian athletes who were national (Australian) representatives in sports demanding a high level of aerobic fitness were recruited. Their ACE genotypes were compared with those of a community control group recruited randomly from the electoral roll. There was no difference in ACE genotype frequencies between the two groups. The DD genotype frequency was 30% in athletes and 29% in the control group, and the II genotype frequency was 22.5 and 22%, respectively. The results do not exclude the possibility that ACE genotype could be related to some attribute relating to a specific type of elite athletic ability or that there may be a difference between genders. Larger studies are desirable.

deletion allele; insertion allele; inheritance; physical performance


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

WE HYPOTHESIZED THAT the deletion (D) allele of the angiotensin-converting enzyme (ACE) gene might contribute to elite athletic ability, on the basis of the following tentative evidence: ACE (which converts angiotensin I to angiotensin II) is widely distributed in cell types, including skeletal muscle (10) and, at least in heart muscle, the enzyme level is higher in D homozygotes than in those with ID or II genotypes (3, 11), where I is the insertion allele; and angiotensin II is a growth factor for cardiac myocytes and fibroblasts (12) and vascular smooth muscle cells (4). Furthermore, inheritance of the D allele may relate not only to myocardial infarction (1, 13) but also to processes such as ventricular hypertrophy (15) and restenosis after coronary balloon angioplasty (17), the latter being regarded as a repair process after vascular wall damage. There is also experimental evidence that angiotensin II is involved more generally in tissue repair (18), and overrepresentation of the DD genotype in centenarians (14) suggested to us (16) that augmented tissue repair responses could be involved in this apparent paradox. Such an effect, coupled with effects on cell growth, would be advantageous to the development of elite athletic ability and sustained high-level performance. On the other hand, there is recent evidence that the II genotype might result in a beneficial training effect in army recruits (6).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The study group of 81 men and 39 women, aged 30 ± 14 (SD) yr, recruited from 1994 to the present, was restricted to those who were, or had been, national (Australian) representatives in highly aerobic sports (hockey, 26; cycling, 25; skiing, 21; track and field, 15; swimming, 13; rowing, 7; gymnastics, 5; other, 8). That is, participants in sports in which a high level of physical performance was not required, such as archery and pistol shooting, or those, such as weight lifting, requiring primarily muscular strength, were not included.

Their results were compared with those of a community control group of healthy subjects, aged 40 ± 6 yr, recruited from the electoral roll (347 men, 338 women). ACE genotyping was carried out as previously described (17).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Figure 1 illustrates the distribution of genotypes in the athletes and control subjects and the close agreement between the two groups, in which the genotypes were, respectively, DD, 30 and 29%; ID, 47.5 and 49%; and II, 22.5 and 22%. The odds ratio for athletes to have the DD genotype was 1.06 (95% confidence interval 0.69-1.62) and the II genotype 1.02 (95% confidence interval 0.64-1.62). Allele frequencies in the athlete and control groups were, respectively, D, 54 and 53%; and I, 46 and 47%, the odds ratio for the D allele in athletes being 1.02 (95% confidence interval 0.77-1.34).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   Angiotensin-converting enzyme (ACE) genotype distribution in elite athletes and control subjects, showing close concordance between 2 groups. D, deletion allele; I, insertion allele.

Five of the athletes included in the above analysis were gymnasts, and eight others competed in sports that possibly did not require an excellent level of aerobic fitness. Excluding those from the analysis did not alter the interpretation, the genotypes in the remaining 107 athletes being DD, 34 (32%), ID, 49 (46%), and II, 24 (22.4%); the odds ratio for athletes to have the DD genotype was 1.15 (95% confidence interval 0.74-1.79), and that for the II genotype was 1.01 (95% confidence interval 0.62-1.65). The numbers studied would have detected, with 90% power, a difference of 15% in the frequency of DD and 14% in that of II genotypes between the two groups; that is, for the DD genotype a frequency of 29 plus 15%, or 44%, would have been detected, and, for the II genotype, 36% would have been detected.

The numbers and proportion of female athletes were smaller than those for men and probably too small for valid comparison with the female control group or the athletic men. There were 75 male athletes among the 107 described above: DD, 30 (40%); ID, 29 (39%); II, 16 (21%); the odds ratio of DD for athleticism was 1.50 (95% confidence interval 0.89-2.50) and of II genotype was 0.98 (95% confidence interval 0.54-1.81). Although 8 of 32 female athletes had the II genotype, it is interesting and provocative that only 4 had the DD genotype.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Montgomery et al. (6) recently reported that the I, rather than the D, allele was significantly associated with the ability of mountaineers to ascend to 7,000 m without oxygen. This particular observation could be related to the specific attribute studied. As reviewed by Cargill and Lipworth (2), the renin-angiotensin system has an important influence on the pulmonary vasculature. It has been subsequently found that exposure to hypoxia increases the expression of ACE in the small pulmonary arteries of the rat and that the pulmonary hypertensive response to hypoxia is reduced by ACE inhibition (7, 8) and specific angiotensin II type 1 receptor inhibition (8, 19). It might be postulated that subjects with the DD genotype have more pulmonary ACE, a more active pulmonary renin-angiotensin system, and greater pulmonary vasoconstriction in response to hypoxia, whereas those with the II genotype are selected for the ability to withstand hypoxia. This hypothesis could be consistent with another recent observation (H. Montgomery, S. Myerson, R. Budget, H. Hemingway, and S. Humphries, personal communication) that the I allele frequency is directly related to the distance over which elite runners compete, suggesting a relationship with some aspect of endurance. However, this proposal is quite contrary to a recent preliminary finding that susceptibility to high-altitude pulmonary hypertension is greater in those with the II genotype (9). That result seems to contradict the finding in mountaineers (6) and was also surprising to the authors, who postulated linkage disequilibrium with some other gene; clearly, the whole question requires further examination, and in larger numbers of subjects.

The finding quoted above on the mountaineers (6) was complemented by a further finding that, after 10 wk of physical training of male army recruits, the ability to perform elbow flexion against resistance was significantly enhanced by inheritance of the I allele (6). However, the results of training of such a community group would not necessarily extrapolate to elite athletic performance, which is likely to depend on complex interactions among musculoskeletal adaptations, cardiovascular and pulmonary variables, tissue repair, and metabolic (5) and psychological factors. Montgomery et al. (5) have subsequently reported that, among the 81 male army recruits studied, those having the II genotype tended to gain total and nonfat mass during training, whereas D carriers tended to lose fat mass, the results being significantly different between these genotypes. This suggests metabolic dependence on ACE genotype, and the implications are unclear but would almost certainly differ among sports.

Our study would have detected an incidence of the II genotype of 40%, which was the incidence of that genotype in the very small group of high-altitude mountaineers (6). However, although we included over 100 athletes, we still did not have sufficient power to detect a smaller, and possibly important, ACE genotype influence on elite athleticism. However, there was no suggestion that the II genotype conferred elite athletic ability and, in men, there was a trend toward the DD genotype. The trend was the opposite in women, but the numbers were too small to draw conclusions. We also had to include athletes involved in a range of sports to obtain sufficient numbers at a truly elite level of physical performance. Our results must, therefore, be regarded as preliminary, but they, and other recent studies (5, 6; H. Montgomery, S. Myerson, R. Budget, H. Hemingway, and S. Humphries, personal communication), emphasize the importance of carrying out very large studies, together with observations on physiological mechanisms, on both male and female athletes involved in various types of sporting activities.


    ACKNOWLEDGEMENTS

We thank Dr. Carmel Goodman, Steve Lawrence, Dave Bishop, Martin Fitzsimmons, Matt Spencer, and Steve Morris for assistance with athlete recruitment; Dr. Konrad Jamrozik for documentation of normal control subjects; and Stacy Cartwright for technical assistance.


    FOOTNOTES

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: R. R. Taylor, Dept. of Cardiology, Royal Perth Hospital, Wellington St., Perth, Western Australia 6000, Australia (E-mail: heletoey{at}rph.health.wa.gov.au).

Received 23 October 1998; accepted in final form 17 May 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Cambien, F., O. Poirier, L. Lecerf, A. Evans, J.-P. Cambou, D. Arveiler, G. Luc, J.-M. Bard, L. Bara, S. Ricard, L. Tiret, P. Amouyel, F. Alhenc-Gelas, and F. Soubrier. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644, 1992[Medline].

2.   Cargill, R. I., and B. J. Lipworth. The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br. J. Clin. Pharmacol. 40: 11-18, 1995[Medline].

3.   Danser, A. H. J., M. A. D. H. Schalekamp, W. A. Bax, A. M. van den Brink, P. R. Saxena, G. A. J. Riegger, and H. Schunkert. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92: 1387-1388, 1995[Medline].

4.   Itoh, H., M. Mukoyama, R. E. Pratt, G. H. Gibbons, and V. J. Dzau. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest. 91: 2268-2274, 1993.

5.   Montgomery, H., P. Clarkson, M. Barnard, J. Bell, A. Brynes, C. Dollery, J. Hajnal, H. Hemingway, D. Mercer, P. Jarman, R. Marshall, K. Prasad, M. Rayson, N. Saeed, P. Talmud, L. Thomas, M. Jubb, M. World, and S. Humphries. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 353: 541-545, 1999[Medline].

6.   Montgomery, H. E., R. Marshall, H. Hemingway, S. Myerson, P. Clarkson, C. Dollery, M. Hayward, D. E. Holliman, M. Jubb, M. World, E. L. Thomas, A. E. Brynes, N. Saeed, N. Barnard, J. D. Bell, K. Prasad, M. Rayson, P. J. Talmud, and S. E. Humphries. Human gene for physical performance. Nature 393: 221-222, 1998[Medline].

7.   Morrell, N. W., E. N. Atochina, K. G. Morris, S. M. Danilov, and K. R. Stenmark. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J. Clin. Invest. 96: 1823-1833, 1995.

8.   Morrell, N. W., K. G. Morris, and K. R. Stenmark. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1186-H1194, 1995[Abstract/Free Full Text].

9.   Morrell, N. W., A. S. Sarybaev, A. Alikhan, M. M. Mirrakhimov, and A. A. Aldashev. ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet 353: 814, 1999[Medline].

10.   Reneland, R., and H. Lithell. Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens. Scand. J. Clin. Lab. Invest. 54: 105-111, 1994[Medline].

11.   Rigat, B., C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86: 1343-1346, 1990.

12.   Sadoshima, J.-I., and S. Izumo. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ. Res. 73: 413-423, 1993[Abstract].

13.   Samani, N. J., J. R. Thompson, L. O'Toole, K. Channer, and K. L. Woods. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94: 708-712, 1996[Medline].

14.   Schächter, F., L. Faure-Delanef, F. Guenot, H. Rouger, P. Froguel, L. Lesueur-Ginot, and D. Cohen. Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 6: 29-32, 1994[Medline].

15.   Schunkert, H., H.-W. Hense, S. R. Holmer, M. Stender, S. Perz, U. Keil, B. H. Lorell, and G. A. J. Riegger. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 330: 1634-1638, 1994[Abstract/Free Full Text].

16.   Van Bockxmeer, F. M. Apo E and ACE genes: impact on human longevity. Nat. Genet. 6: 4-5, 1994[Medline].

17.   Van Bockxmeer, F. M., C. D. S. Mamotte, F. A. Gibbons, V. Burke, and R. R. Taylor. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation 92: 2066-2071, 1995[Medline].

18.   Weber, K. T. Metabolic responses of extracellular matrix in tissue repair. Ann. Med. 29: 333-338, 1997[Medline].

19.   Zhao, L., R. al-Tubuly, A. Sebkhi, A. A. Owji, D. J. Nunez, and M. R. Wilkins. Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br. J. Pharmacol. 119: 1217-1222, 1996[Medline].


J APPL PHYSIOL 87(3):1035-1037
8570-7587/99 $5.00 Copyright © 1999 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
C. Yamin, O. Amir, M. Sagiv, E. Attias, Y. Meckel, N. Eynon, M. Sagiv, and R. E. Amir
ACE ID genotype affects blood creatine kinase response to eccentric exercise
J Appl Physiol, December 1, 2007; 103(6): 2057 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
O. Amir, R. Amir, C. Yamin, E. Attias, N. Eynon, M. Sagiv, M. Sagiv, and Y. Meckel
Human, Environmental & Exercise: The ACE deletion allele is associated with Israeli elite endurance athletes
Exp Physiol, September 1, 2007; 92(5): 881 - 886.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
W. R Thompson and S. A Binder-Macleod
Association of Genetic Factors With Selected Measures of Physical Performance
Physical Therapy, April 1, 2006; 86(4): 585 - 591.
[Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
B Walpole, T D Noakes, M Collins, and R J Trent
Growth hormone 1 (GH1) gene and performance and post-race rectal temperature during the South African Ironman triathlon * Commentary
Br. J. Sports Med., February 1, 2006; 40(2): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. B Psychol. Sci. Soc. Sci.Home page
E. L. Grigorenko
The Inherent Complexities of Gene-Environment Interactions
J. Gerontol. B. Psychol. Sci. Soc. Sci., March 1, 2005; 60(suppl_Special_Issue_1): 53 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Heled, D. S. Moran, L. Mendel, A. Laor, E. Pras, and Y. Shapiro
Human ACE I/D polymorphism is associated with individual differences in exercise heat tolerance
J Appl Physiol, July 1, 2004; 97(1): 72 - 76.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. G. Williams, S. S. Dhamrait, P. T. E. Wootton, S. H. Day, E. Hawe, J. R. Payne, S. G. Myerson, M. World, R. Budgett, S. E. Humphries, et al.
Bradykinin receptor gene variant and human physical performance
J Appl Physiol, March 1, 2004; 96(3): 938 - 942.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. Bahi, N. Koulmann, H. Sanchez, I. Momken, V. Veksler, A. X. Bigard, and R. Ventura-Clapier
Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats?
J Appl Physiol, January 1, 2004; 96(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Tiainen, S. Sipila, M. Alen, E. Heikkinen, J. Kaprio, M. Koskenvuo, A. Tolvanen, S. Pajala, and T. Rantanen
Heritability of maximal isometric muscle strength in older female twins
J Appl Physiol, January 1, 2004; 96(1): 173 - 180.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. M. Fuentes, M. Perola, A. Nissinen, and J. Tuomilehto
ACE gene and physical activity, blood pressure, and hypertension: a population study in Finland
J Appl Physiol, June 1, 2002; 92(6): 2508 - 2512.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. A. Sonna, M. A. Sharp, J. J. Knapik, M. Cullivan, K. C. Angel, J. F. Patton, and C. M. Lilly
Angiotensin-converting enzyme genotype and physical performance during US Army basic training
J Appl Physiol, September 1, 2001; 91(3): 1355 - 1363.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. Rankinen, B. Wolfarth, J.-A. Simoneau, D. Maier-Lenz, R. Rauramaa, M. A. Rivera, M. R. Boulay, Y. C. Chagnon, L. Perusse, J. Keul, et al.
No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status
J Appl Physiol, May 1, 2000; 88(5): 1571 - 1575.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, R. R.
Right arrow Articles by van Bockxmeer, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, R. R.
Right arrow Articles by van Bockxmeer, F. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online